Symposium & Continuing Education at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
In recent years, immunotherapy has established itself as the fourth pillar of cancer treatment alongside surgery, radiation, and chemotherapy. The use of immunotherapy in neuro-oncology presents particular challenges but also offers great hope.
To mark the opening of its new GMP laboratory, the IOZK will host a scientific symposium with international speakers on the topic of "Immunotherapy in Neuro-Oncology."A tour of the laboratories is on the agenda. We look forward to seeing you there.
Fri, September 6, 2019 | 10:00 a.m.–6:00 p.m. | Steigenberger Hotel Cologne | Habsburgerring 9–13 | 50674 Cologne, Germany
CME credits: 9 | The number of participants is limited. The conference fee is €45.00.
Venue: Steigenberger Hotel Cologne | Habsburgerring 9-13 | 50674 Cologne
GMP laboratory: IOZK Immun-Onkologisches Zentrum Köln (Cologne Immunology and Oncology Center) | Hohenstaufenring 30-32 | 50674 Cologne
Please use the attached form to register and send it to us by fax, email, or post.
Download: Invitation (PDF)
Download: Registration form (PDF)
Scientific Program
09:30 Registration
Location: Steigenberger HotelCologne
10:00–10:15 Welcome
Dr. Wilfried Stücker| Managing Director and Head of the IOZK Working Group| IOZK Immun-Onkologisches Zentrum Köln (Cologne Immun-Oncology Center)
10:15 a.m. - 10:45 a.m.
Molecular detection of circulating tumor cells and characterization of therapy-related drug
metabolizing genes
Dr. Lothar Prix | Laboratory Diagnostics | LADR Laboratory Center Recklinghausen | Germany
10:45 a.m. - 11:15 a.m.
Results against glioblastoma by Sitoiganap
Prof. Dr. Apostolos Stathopoulos| Chief Physician , Neurosurgery| Euroclinic ,Athens , Greece
11:15 a.m. - 11:45 a.m.
Future developments of brain tumor vaccines
Prof. Dr. Matthias Eyrich| Pediatric Clinic| University Hospital Würzburg| Germany
11:45 a.m. - 12:15 p.m.
Multimodal Immunotherapy at IOZK
Stefaan Van Gool, MD, PhD | Translational Oncology | IOZK Immun-Onkologisches Zentrum Köln (Cologne Immunooncology Center) | Germany
12:15 p.m. - 2:15 p.m.
Lunch and guided tour of the IOZK clinical unit and the IOZK GMP laboratory
Location: IOZK Center| Immun-Onkologisches Zentrum Köln (Cologne Immunology and Oncology Center)| Hohenstaufenring 30–32, 50674 Cologne, Germany
2:15 p.m. - 2:45 p.m.
Immuno-radiotherapy to prevent brain metastases from lung cancer
Prof. Dr. Dirk de Ruysscher| Radiooncology | MaastrichtUniversity | Netherlands
2:45 p.m. - 3:15 p.m.
GlioVax: Dendritic cell vaccination therapy for glioblastoma
PD Dr. Rüdiger Sorg| Institute for Transplantation Diagnostics & Cell Therapies| Heinrich Heine University Düsseldorf| Germany
3:15 p.m. - 3:45 p.m.
Oncolytic virus for pediatric brain tumors: from the bench to the clinic
Prof. Dr. Marta Alonso| Pediatric Clinic| Clinica Universidad Navarra| Pamplona , Spain
3:45 p.m. - 4:15 p.m. Coffee break
4:15 p.m. - 4:45 p.m.
Update on clinical results from a cohort of GBM patients treated with autologous dendritic cells
Prof. Dr. Ricardo Díez Valle| Neurosurgery | Clinica Universidad Navarra| Pamplona , Spain
4:45 p.m. - 5:15 p.m.
Immune monitoring of glioblastoma patients treated with dendritic cell immunotherapy
Prof. Dr. Serena Pellegatta| Molecular Neuro-Oncology| Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta| Milan , Italy
5:15 p.m. - 5:45 p.m.
The Pan Tum Detect blood test (Apo10, TKTL1) and current immunophenotyping to monitor the response to immunotherapy
Dr. Oliver Feyen | Laboratory Diagnostics | IOZK Immun-Onkologisches Zentrum Köln (Cologne Immunology and Oncology Center) | Germany
5:45 p.m. - 6:00 p.m. Closing remarks
Dr. Wilfried Stücker| Managing Director and Head of the IOZK Working Group| IOZK Immun-Onkologisches Zentrum Köln (Cologne Immun-Oncology Center)
